Pfizer/BioNTech Updated Covid-19 Vaccine Gets Canadian Approval
By Josh Beckerman
Pfizer and BioNTech said drug regulator Health Canada approved their updated Covid-19 vaccine, which will be available in the coming weeks.
Pfizer's Canadian business and Germany's BioNTech said the vaccine will be available in Canada as a single dose for people age 5 and up, regardless of Covid-19 vaccination history. For children 6 months through 4 years old, it is authorized as a three-dose series in those without a history of completion of a Covid-19 primary vaccination course, or as a single dose for those who have completed a primary vaccination course.
Last week, a committee from the European Medicine Agency recommended marketing authorization for the vaccine.
In August, the Food and Drug Administration approved the Pfizer/BioNTech vaccine, as well as Moderna's. The new vaccines target an offshoot of Omicron known as the KP.2 strain. Also approved was a Novavax vaccine that targets the JN.1 strain and has demonstrated cross-reactivity against JN.1 lineage viruses.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
September 24, 2024 14:17 ET (18:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now